R
Richard R. Love
Researcher at International Breast Cancer Research Foundation
Publications - 147
Citations - 7426
Richard R. Love is an academic researcher from International Breast Cancer Research Foundation. The author has contributed to research in topics: Breast cancer & Tamoxifen. The author has an hindex of 40, co-authored 147 publications receiving 7237 citations. Previous affiliations of Richard R. Love include University of Wisconsin-Madison & Ohio State University.
Papers
More filters
Journal ArticleDOI
Effects of Tamoxifen on Bone Mineral Density in Postmenopausal Women with Breast Cancer
Richard R. Love,Mazess Rb,H.S. Barden,S. Epstein,Polly A. Newcomb,Jordan Vc,P.P. Carbone,David L. DeMets +7 more
TL;DR: In postmenopausal women, treatment with tamoxifen is associated with preservation of the bone mineral density of the lumbar spine, and whether this favorable effect on bone mineraldensity is accompanied by a decrease in the risk of fractures remains to be determined.
Journal ArticleDOI
Effects of Tamoxifen on Cardiovascular Risk Factors in Postmenopausal Women
Richard R. Love,Donald A. Wiebe,Polly A. Newcomb,Linda D. Cameron,Howard Leventhal,Howard Leventhal,Virgil Craig Jordan,Jan Feyzi,David L. DeMets +8 more
TL;DR: During 2 years of treatment, tamoxifen showed generally favorable effects on the lipid and lipoprotein profile of treated postmenopausal women, which may partially explain the decrease in adverse events and in mortality related to coronary heart disease seen in patients receiving adjuvant tamoxIFen treatment.
Journal ArticleDOI
FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene
Tao Zuo,Lizhong Wang,Carl Morrison,Xing Chang,Huiming Zhang,Weiquan Li,Yan Liu,Yin Wang,Xingluo Liu,Michael W.Y. Chan,Jin-Qing Liu,Richard R. Love,Chang Gong Liu,Virginia Godfrey,Rulong Shen,Tim H M Huang,Tianyu Yang,Bae Keun Park,Cun-Yu Wang,Pan Zheng,Yang Liu +20 more
TL;DR: The data demonstrate that FOXP3 is an X-linked breast cancer suppressor gene and an important regulator of the HER-2/ErbB2 oncogene.
Journal ArticleDOI
Effects of Tamoxifen Therapy on Lipid and Lipoprotein Levels in Postmenopausal Patients With Node-Negative Breast Cancer
Richard R. Love,Polly A. Newcomb,Donald A. Wiebe,Tanya S. Surawicz,Virgil Craig Jordan,Paul P. Carbone,David L. DeMets +6 more
TL;DR: It is concluded that during the first 12 months of treatment, tamoxifen exerts a favorable effect on the lipid profile in postmenopausal women with early stage breast cancer.
Journal ArticleDOI
Side effects and emotional distress during cancer chemotherapy.
TL;DR: Chemotherapy side effects, patient distress, and patient‐practitioner communication were evaluated in an inception sample of 238 patients with breast cancer or malignant lymphoma and communication between patient and practitioner was found to be inadequate.